WASHINGTON -- The US Food and Drug Administration gave the green light Monday to updated COVID-19 vaccines from Moderna and Pfizer/BioNTech amid rising cases and hospitalizations. Both vaccine ...

Moderna said Wednesday that its experimental mRNA-based seasonal flu vaccine generated a stronger immune response against four strains of the flu virus than a currently marketed vaccine in a Phase 3 ...

(Reuters) -Moderna topped Wall Street sales expectations and reported a lower-than-expected second-quarter loss on Friday, driven by robust Spring COVID booster demand and aggressive cost cuts.

SAN FRANCISCO -- Moderna announced people may need a second booster to increase protection. But is a fourth shot the right approach? ABC7 News reporter Luz Pena from San Francisco spoke to multiple ...

As of Nov. 21, 5.8% of children and 13.8% of adults in the U.S. have received a COVID-19 vaccine during this ...

Simultaneous administration of a COVID-19 mRNA booster shot and the seasonal influenza vaccine slightly increased the risk of systemic reactions during the following week compared with a booster shot ...

Biotech company Moderna said Thursday it plans to cut 10% of its global workforce and expects to have fewer than 5,000 employees by the end of the year. The move is part of the company's ongoing ...

RUNNEMEDE, New Jersey (WPVI) -- This week, Pfizer asked the FDA for authorization of a second COVID-19 booster shot for senior citizens to fight waning immunity. On Thursday, Moderna asked for that ...

Moderna MRNA announced that its seasonal influenza vaccine candidate, mRNA-1010, achieved superior relative vaccine efficacy (rVE) than an approved flu shot marketed by GSK plc GSK in a phase III ...

Neutralizing antibody levels rose 37-fold one month after the booster was given. Moderna announced Monday that its COVID-19 vaccine booster increases antibody levels against the omicron variant within ...